What is the recommended initial management for a newborn with classic salt‑wasting 21‑hydroxylase deficiency (congenital adrenal hyperplasia)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Classic Salt-Wasting 21-Hydroxylase Deficiency in Newborns

Immediate treatment of a newborn with classic salt-wasting congenital adrenal hyperplasia requires three components: intravenous hydrocortisone 100 mg followed by stress-dose glucocorticoid replacement, fludrocortisone 100-200 µg daily, and aggressive fluid resuscitation with isotonic saline if the infant presents in adrenal crisis. 1, 2

Acute Stabilization (First 24-48 Hours)

If Presenting in Adrenal Crisis

  • Administer IV hydrocortisone 100 mg bolus immediately—do not delay for diagnostic testing 3, 1
  • Infuse 0.9% normal saline at 1 L/hour (or age-appropriate rate) until hemodynamic stability is achieved 3, 1
  • Continue hydrocortisone 100 mg IV every 6-8 hours until the infant is stable and able to take oral medications 1
  • Draw blood for cortisol and ACTH before giving steroids if possible, but never delay treatment 3

If Diagnosed Before Crisis (e.g., Newborn Screening or Ambiguous Genitalia)

  • Start oral hydrocortisone immediately at stress doses (approximately 25-100 mg/m² per day in divided doses) 4, 5
  • Begin fludrocortisone 100-200 µg daily as a single morning dose 2, 6, 5
  • Add oral sodium chloride supplementation (1-2 g daily in divided doses) 7, 5

Maintenance Therapy (After Stabilization)

Glucocorticoid Replacement

  • Hydrocortisone is the only appropriate glucocorticoid for infants and children with CAH—never use dexamethasone or long-acting steroids 8, 1, 4
  • Target maintenance dose: 10-15 mg/m² per day (approximately 6-10 mg/m² per day), divided into 3 doses 1, 4
  • Typical dosing schedule: give the first dose immediately upon awakening, second dose at midday, and third dose 4-6 hours before bedtime 8, 1
  • For a newborn, this translates to approximately 2.5 mg three times daily initially, adjusted based on body surface area 4, 5

Mineralocorticoid Replacement

  • All infants with classic salt-wasting CAH require fludrocortisone—this is not optional 2, 5
  • Starting dose: 100-200 µg daily as a single morning dose 2, 6, 5
  • Infants typically require higher doses per body surface area than older children or adults 7, 6
  • A practical dosing algorithm based on age: 6
    • 0-6 months: 200 µg daily
    • 7-18 months: 150 µg daily
    • 19-24 months: 125 µg daily

Sodium Supplementation

  • Add oral sodium chloride 1-2 g daily in divided doses during infancy 7, 5
  • Sodium needs are highest in the first 6 months and decrease as the infant matures 6
  • Advise unrestricted salt intake in the diet as the child grows 8, 7

Monitoring Parameters

Biochemical Monitoring

  • Check serum sodium, potassium, and glucose at diagnosis and during the first month, then monthly for the first 6 months 6, 5
  • Measure plasma renin activity (PRA) to guide fludrocortisone dosing—target is upper normal range 7, 6
  • Monitor 17-hydroxyprogesterone (17-OHP) and androstenedione every 3 months to assess glucocorticoid adequacy 4, 5
  • The absence of hyperkalemia does not rule out inadequate mineralocorticoid replacement, as hyperkalemia occurs in only 50% of cases 3

Clinical Monitoring

  • Assess blood pressure in supine and standing positions at each visit—orthostatic hypotension indicates under-replacement 7
  • Monitor for salt craving, which suggests inadequate mineralocorticoid replacement 8, 7
  • Track growth velocity and weight gain monthly—over-replacement causes excessive weight gain and growth suppression 1, 4
  • Check for peripheral edema or hypertension, which indicate fludrocortisone over-replacement 7

Critical Pitfalls to Avoid

Dosing Errors

  • Never use prednisolone, prednisone, or dexamethasone as maintenance therapy in infants—only hydrocortisone is appropriate 8, 1, 4
  • Do not under-dose fludrocortisone out of fear of hypertension—under-replacement predisposes to recurrent adrenal crises 7
  • Never stop fludrocortisone completely even if mild hypertension develops—reduce the dose instead 7

Monitoring Failures

  • Do not rely on electrolytes alone to assess adequacy—hyponatremia may be mild and hyperkalemia is absent in 50% of cases 3
  • Never fast an infant with CAH for more than 4-6 hours—check blood glucose hourly if fasting exceeds 4 hours 8
  • Do not delay treatment of suspected adrenal crisis to obtain diagnostic tests—mortality is high if untreated 3, 1

Drug Interactions

  • Avoid medications that interfere with fludrocortisone: diuretics, acetazolamide, NSAIDs, and liquorice 8, 7
  • Avoid grapefruit juice and liquorice, which potentiate mineralocorticoid effects 8, 7

Stress Dosing and Emergency Preparedness

Sick Day Rules

  • Triple the hydrocortisone dose during fever >38.5°C, vomiting, diarrhea, or significant illness 1, 4
  • If the infant cannot tolerate oral medications due to vomiting, administer hydrocortisone 100 mg IM immediately and seek emergency care 1
  • Continue fludrocortisone at the usual dose during illness—only glucocorticoid needs increase 7

Family Education

  • Train parents to administer IM hydrocortisone 100 mg and provide an emergency injection kit 1
  • Ensure the infant wears a medical alert bracelet indicating adrenal insufficiency 1, 7
  • Provide a steroid emergency card with dosing instructions for healthcare providers 8, 1

Surgical Stress Dosing

For Feminizing Genitoplasty or Other Major Surgery

  • Administer hydrocortisone 2 mg/kg IV at induction of anesthesia 8
  • Continue hydrocortisone 2 mg/kg IV every 4 hours postoperatively, or use a continuous infusion of 50 mg/m²/day 8
  • Resume oral hydrocortisone at double the maintenance dose once enteral intake is established, then taper to normal dosing over 48 hours 8
  • Resume fludrocortisone at the usual dose once oral intake is established 7

References

Guideline

Treatment of Adrenal Insufficiency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosing Adrenal Insufficiency in Hypo-osmolar Hyponatremia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Fludrocortisone Dosing in Congenital Adrenal Hyperplasia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the treatment for a patient with suspected adrenal hyperplasia?
What is the most appropriate next step for a baby with congenital adrenal hyperplasia (CAH) presenting with hypoglycemia, hyponatremia, and hyperkalemia?
What is the primary treatment for Congenital Adrenal Hyperplasia (CAH)?
What is the primary cause and treatment of Congenital Adrenal Hyperplasia (CAH)?
What is the most appropriate next step for a baby with congenital adrenal hyperplasia (CAH) presenting with hypoglycemia, hyponatremia, and hyperkalemia?
What is the recommended acute management for an adult with chronic obstructive pulmonary disease presenting with an exacerbation characterized by increased dyspnea, cough, and sputum volume or purulence?
In an asymptomatic 68‑year‑old woman with mild hyperkalaemia (serum potassium 5.7 mmol/L) identified on routine health screening, what is the appropriate management and when should the potassium be rechecked?
What medication is recommended as first‑line therapy for a patient with lactose intolerance?
In a 40‑year‑old pregnant woman with advanced maternal age, oocyte‑donation conception, family history of pre‑eclampsia, endometriosis, prior miscarriages, and isolated ANA positivity who is gaining 3–4 kg per month, what investigations are indicated?
What is the recommended treatment for acute rejection of a kidney transplant?
What is the recommended management for an asymptomatic 67‑year‑old woman with serum potassium 5.7 mmol/L (no chest pain or dyspnoea) according to NICE CKS guidelines?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.